Easier diabetes meds for kids? liquid glibenclamide trial shows promise
NCT ID NCT02375828
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a new liquid version of the diabetes drug glibenclamide in 10 children with neonatal diabetes. The goal was to see if the liquid form is easier to take and as safe as the standard pills. Children first took the pill form for one month, then switched to the liquid for four months. Researchers measured how well the liquid was accepted and any side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- glibenclamide (a diabetes drug)
- What this could lead to
- If successful, this could provide a more child-friendly liquid version of glibenclamide, making it easier for infants and young children with neonatal diabetes to take their daily medication.
- What could go wrong
- This is a small, completed trial with only 10 participants, so results may not apply to all children. The study focuses on ease of use and safety, not on curing the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL DIABETES SECONDARY TO MUTATION IN THE POTASSIUM CHANNEL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Universitaire Necker Enfants Malades
Paris, 7501, France